Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

All Content

  • 1
    News

    Heparin’s COVID-19 benefit greatest in moderately ill patients

    August 13, 2021

    A multiplatform trial reported that therapeutic heparin improved outcomes in moderately ill COVID-19 patients but not in critically ill patients.

  • News

    Tachycardia syndrome may be distinct marker for long COVID

    August 13, 2021

    Post-COVID patients with palpitations or chest pain should undergo a cardiac workup, new research suggests. The data also shed light on potential treatments.

  • 1
    News

    HM administrators plan for 2021 and beyond

    August 13, 2021

    “If there was ever doubt that the hospitalists are the beating heart of the hospital, this doubt is now gone,” said Elda Dede, FHM.

  • 1
    News

    FDA authorizes booster shot for immunocompromised Americans

    August 13, 2021

    Those eligible for a third dose include solid organ transplant recipients, those undergoing cancer treatments, and people with autoimmune diseases that suppress their immune systems.

  • 1
    News

    Move from awareness to action to combat racism in medicine

    August 12, 2021

    Calls to action to address structural racism include learning from policies, prioritizing voting, and educating children.

  • 1
    News

    SHM’s Center for Quality Improvement to partner on NIH grant

    August 12, 2021

    Study will identify interventions to rapidly improve care for children hospitalized with respiratory illnesses.

  • News

    Febrile infant guideline allows wiggle room on hospital admission, testing

    August 12, 2021

    Evidence-based guidelines use language to guide, but not direct, clinicians in balancing the risks of infections and invasive procedures.

  • 1
    News

    Hospitals struggle to find nurses, beds, even oxygen as Delta surges

    August 12, 2021

    “We have a vaccine, which is the key to ending this pandemic and people just refuse to take it, and so I think we’re very frustrated.”

  • News

    Pandemic demand for NPs soars, softens for primary care: Report

    August 12, 2021

    “NPs are coming into their own in a market that puts a premium on easy access to care and cost containment.”

  • 1
    News

    FDA may okay COVID booster for vulnerable adults before weekend: Media

    August 12, 2021

    Between one-third and one-half of immunocompromised patients who didn’t develop detectable levels of virus-fighting antibodies after two doses of a COVID vaccine will respond to a third dose.

Previous1 … 27 28 29 30 31 … 861Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences